State Street’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.2M Sell
2,464,017
-1,389,934
-36% -$19.1M ﹤0.01% 1943
2025
Q4
$53.2M Buy
3,853,951
+1,962,486
+104% +$46.2M ﹤0.01% 1706
2025
Q3
$46.2M Buy
1,891,465
+503,357
+36% +$12.3M ﹤0.01% 1763
2025
Q2
$32.1M Buy
1,388,108
+16,611
+1% +$438K ﹤0.01% 1927
2025
Q1
$37M Buy
1,371,497
+103,548
+8% +$3.9M ﹤0.01% 1806
2024
Q4
$67.9M Sell
1,267,949
-93,229
-7% -$4.93M ﹤0.01% 1561
2024
Q3
$61.8M Sell
1,361,178
-40,056
-3% -$1.74M ﹤0.01% 1597
2024
Q2
$58.7M Buy
1,401,234
+1,001,767
+251% +$47M ﹤0.01% 1581
2024
Q1
$15M Buy
399,467
+51,882
+15% +$1.13M ﹤0.01% 2338
2023
Q4
$3.73M Buy
347,585
+16,014
+5% +$138K ﹤0.01% 3085
2023
Q3
$3.34M Sell
331,571
-1,019
-0.3% -$11.8K ﹤0.01% 3108
2023
Q2
$3.95M Buy
332,590
+33,961
+11% +$454K ﹤0.01% 3114
2023
Q1
$3.61M Buy
298,629
+15,519
+5% +$258K ﹤0.01% 3113
2022
Q4
$3.73M Buy
283,110
+18,903
+7% +$277K ﹤0.01% 3169
2022
Q3
$3.58M Buy
264,207
+185
+0.1% +$2.47K ﹤0.01% 3220
2022
Q2
$3.22M Buy
264,022
+22,024
+9% +$261K ﹤0.01% 3310
2022
Q1
$3.47M Buy
241,998
+30,432
+14% +$498K ﹤0.01% 3345
2021
Q4
$4.17M Buy
211,566
+36,922
+21% +$774K ﹤0.01% 3327
2021
Q3
$3.78M Buy
+174,644
New +$5.02M ﹤0.01% 3378

Other funds holding JANX